Lymphomania. Non-Hodgkin's Lymphoma As Possibly Viewed Through the Eyes of Lewis Carroll

Overview

Journal J R Soc Med

Specialty General Medicine

Date 1987 Feb 1

PMID 3560148

Authors

E Glatstein

Affiliations

Soon will be listed here.

References

Carbone P, Kaplan H, MUSSHOFF K, SMITHERS D, TUBIANA M . Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971; 31(11):1860-1. View

Devita Jr V, Canellos G, Chabner B, Schein P, Hubbard S, Young R . Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet. 1975; 1(7901):248-50. DOI: 10.1016/s0140-6736(75)91142-3. View

Fuks Z, Glatstein E, Kaplan H . Patterns of presentation and relapse in the non-Hodgkin's lymphomata. Br J Cancer Suppl. 1975; 2:286-97. PMC: 2149558. View

Anderson T, Bender R, Fisher R, DEVITA V, Chabner B, BERARD C . Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup. Cancer Treat Rep. 1977; 61(6):1057-66. View

Coleman C, Williams C, Flint A, Glatstein E, Rosenberg S, Kaplan H . Hematologic neoplasia in patients treated for Hodgkin's disease. N Engl J Med. 1977; 297(23):1249-52. DOI: 10.1056/NEJM197712082972303. View

Rosenberg S . Karnofsky memorial lecture. The low-grade non-Hodgkin's lymphomas: challenges and opportunities. J Clin Oncol. 1985; 3(3):299-310. DOI: 10.1200/JCO.1985.3.3.299. View

Cabanillas F, Bodey G, Freireich E . Management with chemotherapy only of stage I and II malignant lymphoma of aggressive histologic types. Cancer. 1980; 46(11):2356-9. DOI: 10.1002/1097-0142(19801201)46:11<2356::aid-cncr2820461107>3.0.co;2-x. View

Miller R, Maloney D, Warnke R, Levy R . Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med. 1982; 306(9):517-22. DOI: 10.1056/NEJM198203043060906. View

COLTMAN Jr C, Dixon D . Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup. Cancer Treat Rep. 1982; 66(4):1023-33. View

10.

Greene M, Young R, Merrill J, DEVITA V . Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma. Cancer Res. 1983; 43(4):1891-8. View

11.

Tester W, Kinsella T, Waller B, Makuch R, Kelley P, Glatstein E . Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. J Clin Oncol. 1984; 2(7):762-9. DOI: 10.1200/JCO.1984.2.7.762. View

12.

Portlock C, Rosenberg S . No initial therapy for stage III and IV non-Hodgkin's lymphomas of favorable histologic types. Ann Intern Med. 1979; 90(1):10-3. DOI: 10.7326/0003-4819-90-1-10. View